Which Hedge Funds Own RXRX — Recursion Pharmaceuticals Inc

15 of the hedge funds we track hold RXRX, worth $293.0M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 2 opened a new position, 5 added, 7 trimmed, 2 exited.

12 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at RXRX · All tracked funds